光明中医
光明中醫
광명중의
Guangming Journal of Chinese Medicine
2015年
11期
2325-2326
,共2页
酒精性肝病%腺苷脱氨酶%肝功能
酒精性肝病%腺苷脫氨酶%肝功能
주정성간병%선감탈안매%간공능
Alcohol liver disease%Adenosine deaminase%Liver function
目的:本实验是为了研究酒精性肝病患者腺苷脱氨酶活性,建立一种早期预警酒精性肝病严重程度的方法。方法60例酒精性肝病患者被分为3组,(脂肪肝20例、酒精性肝炎22例、酒精性肝硬化18例);对照组健康男性60例,同时测定腺苷脱氨酶活性、肝功能参数。结果酒精性肝病患者腺苷脱氨酶均显著高于对照组,酒精性肝炎和肝硬化组腺苷脱氨酶均显著高于脂肪肝组和对照组。结论本研究显示增高的腺苷脱氨酶、AST、ALT、GGT提示肝细胞的破坏,酒精性肝病患者血清腺苷脱氨酶检测是一种无创性的检查,很容易在基层医院推广,有助于早期疾病诊断,在疾病发展到严重阶段之前进行诊治和行为干预。
目的:本實驗是為瞭研究酒精性肝病患者腺苷脫氨酶活性,建立一種早期預警酒精性肝病嚴重程度的方法。方法60例酒精性肝病患者被分為3組,(脂肪肝20例、酒精性肝炎22例、酒精性肝硬化18例);對照組健康男性60例,同時測定腺苷脫氨酶活性、肝功能參數。結果酒精性肝病患者腺苷脫氨酶均顯著高于對照組,酒精性肝炎和肝硬化組腺苷脫氨酶均顯著高于脂肪肝組和對照組。結論本研究顯示增高的腺苷脫氨酶、AST、ALT、GGT提示肝細胞的破壞,酒精性肝病患者血清腺苷脫氨酶檢測是一種無創性的檢查,很容易在基層醫院推廣,有助于早期疾病診斷,在疾病髮展到嚴重階段之前進行診治和行為榦預。
목적:본실험시위료연구주정성간병환자선감탈안매활성,건립일충조기예경주정성간병엄중정도적방법。방법60례주정성간병환자피분위3조,(지방간20례、주정성간염22례、주정성간경화18례);대조조건강남성60례,동시측정선감탈안매활성、간공능삼수。결과주정성간병환자선감탈안매균현저고우대조조,주정성간염화간경화조선감탈안매균현저고우지방간조화대조조。결론본연구현시증고적선감탈안매、AST、ALT、GGT제시간세포적파배,주정성간병환자혈청선감탈안매검측시일충무창성적검사,흔용역재기층의원추엄,유조우조기질병진단,재질병발전도엄중계단지전진행진치화행위간예。
Objective The present study was designed to evaluate adenosine deaminase activity levels in patients with alcoholic liver disease to establish the method to monitor the severity of this disease.Methods 60 cases of patients with alcohol liver disease were divided into three groups ( there was 20 cases of patients with fatty liver, 22 cases of patients with alcoholic hepatitis and 18 cases of patients with cirrhosis and control group of 60 healthy males were enrolled in the study.Adenosine deaminase and liver function test parameters of the two groups were analyzed.Results Adenosine deaminase of the patients with alcohol liver disease was significantly higher than that of the control groups.Adenosine deaminase of patients with alcoholic hepatitis and patients with cirrhosis were significantly higher than that of the fatty liver group and the control group.Conclusions The present study demonstrated the increased adenosine deaminase, AST, ALT and GGT indicated live cells were damaged.The estimation of serum adenosine deaminase level in the patients of alcoholic liver disease was an important non invasive prognostic tool which may be widely used in primary hospitals and may be helpful in the treatment and behavior interventions before the diseases develop the severe stages.